• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, September 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Short-term and oncological outcomes of natural orifice specimen extraction surgery (NOSES) for colorectal cancer in China: a national database study of 5055 patients

Bioengineer by Bioengineer
June 14, 2022
in Health
Reading Time: 3 mins read
0
1. Main surgical procedures of specimen extraction in eversion-resection technique of transanal NOSES.
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

This study is led by Prof. Xishan Wang (Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College), Prof. Chuangang Fu (Shanghai East Hospital, Tongji University School of Medicine), Dr. Xu Guan (Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College), Dr. Xiyue Hu (Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) and Prof. Zheng Jiang (Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College), on behalf of China NOSES Alliance.

1. Main surgical procedures of specimen extraction in eversion-resection technique of transanal NOSES.

Credit: Science China Press

This study is led by Prof. Xishan Wang (Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College), Prof. Chuangang Fu (Shanghai East Hospital, Tongji University School of Medicine), Dr. Xu Guan (Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College), Dr. Xiyue Hu (Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College) and Prof. Zheng Jiang (Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College), on behalf of China NOSES Alliance.

With the rapid development of minimally invasive surgery for the treatment of colorectal diseases, novel surgical techniques aiming at reducing surgical trauma have become frequently discussed issues. By avoiding auxiliary abdominal incision for specimen extraction, natural orifice specimen extraction surgery (NOSES), including transvaginal specimen extraction (TVSE) and transanal specimen extraction (TASE), is thought to be one of the least invasive options in the treatment of colorectal cancer (CRC). However, most previous studies concerning the safety and effectiveness of NOSES are single-centered with limited sample sizes. Whether previous findings can be generalized to a wider patient population remains unclear.

This study performed the first nationwide large-scale study to confirm the safety and feasibility of NOSES for CRC by analyzing the short-term and long-term oncological outcomes. CRC patients who received the NOSES procedure as the primary therapy between August 2008 and May 2021 were registered in this database. All patients were pathologically diagnosed with malignancy.

A total of 5055 CRC patients who underwent NOSES were identified in the database. The overall postoperative complication rate was 14.1%. For rectal cancer, the complication rates of TASE and TVSE were 15.3% and 11.5%, respectively (P = 0.107). The rectovaginal fistula rate for TVSE was significantly higher than TASE (2.1% vs 0.4%, P = 0.005). For colon cancer, the complication rates of TASE and TVSE were 11.1% and 11.3%, respectively (P = 0.924), and there was no difference in all subtypes of complications between TASE and TVSE. These results reveal that the incidence of postoperative complications after NOSES was consistent with that reported in previous studies concerning CLS.

After exclusion of patients with a follow-up period of < 12 months and patients without follow-up data, 701 patients were left for survival analysis with a median follow-up of 25.3 months. The 3-year OS, 3-year DFS, and 3-year LRR were 93.2%, 82.2%, and 3.6%, respectively. These data show that NOSES does not result in a poor oncological prognosis in terms of long-term survival, thus further confirming the oncological safety of NOSES.

Also, a systematic review was performed to compare the short-term and oncological outcomes between NOSES and CLS, and 17 studies were included for further analyses. This review has shown that compared with CLS, NOSES presented lower complication rates and several advantages in postoperative recovery, which mainly include earlier postoperative flatus time and shorter hospital stay.

In summary, this is the first national database analysis report confirming that NOSES could achieve good short-term and oncological outcomes for CRC patients. However, NOSES should be performed cautiously by experienced surgeons in selected CRC patients.

https://www.sciencedirect.com/science/article/pii/S2095927322002213



Journal

Science Bulletin

DOI

10.1016/j.scib.2022.05.014

Share12Tweet8Share2ShareShareShare2

Related Posts

Predictive Lab Tests for Cardiac Events Remain Rare but Are on the Rise

September 24, 2025

New App Developed to Enhance Cannabis Use Management

September 24, 2025

FAU Study Identifies Single-Drug Treatment Targeting PTSD, Pain, and Alcohol Misuse

September 24, 2025

Epigenomics Uncover Trained Immunity in Bronchial Cells

September 24, 2025

POPULAR NEWS

  • Physicists Develop Visible Time Crystal for the First Time

    Physicists Develop Visible Time Crystal for the First Time

    70 shares
    Share 28 Tweet 18
  • Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases

    50 shares
    Share 20 Tweet 13
  • Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation

    49 shares
    Share 20 Tweet 12
  • Rapid Spread of Drug-Resistant Fungus Candidozyma auris in European Hospitals Prompts Urgent Warning from ECDC

    48 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Predictive Lab Tests for Cardiac Events Remain Rare but Are on the Rise

Predicting Infant Motor Outcomes via NSE and S100B

How Chronic Cellular Stress and Fatty Acids Fuel Cancer-Associated Gut Bacteria

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.